Current Diabetes Reports

, 16:8 | Cite as

Metabolic Syndrome in Children and Adolescents: a Critical Approach Considering the Interaction between Pubertal Stage and Insulin Resistance

Pediatric Type 2 Diabetes (PS Zeitler, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Pediatric Type 2 Diabetes

Abstract

Pediatricians increasingly diagnose the metabolic syndrome (MetS) in recent years to describe cardiovascular risk and to guide management of the obese child. However, there is an ongoing discussion about how to define the MetS in childhood and adolescence. Since insulin resistance—the major driver of MetS—is influenced by pubertal stage, it is questionable to use definitions for MetS in children and adolescents that do not take into account pubertal status. A metabolic healthy status in prepubertal stage does not predict a metabolic healthy status during puberty. Furthermore, cardiovascular risk factors improve at the end of puberty without treatment. However, having a uniform internationally accepted definition of the MetS for children and adolescents would be very helpful for the description of populations in different studies. Therefore, the concept of MetS has to be revisited under the influence of puberty stage.

Keywords

Puberty Definition Metabolic Syndrome Intervention Obesity 

References

Papers of particular interest, published recently, have been highlighted as: • Of importance, •• Of major importance

  1. 1.
    Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity: public-health crisis, common sense cure. Lancet. 2002;360(9331):473–82.CrossRefPubMedGoogle Scholar
  2. 2.
    Han JC, Lawlor DA, Kimm SY. Childhood obesity. Lancet. 2010;375(9727):1737–48.PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    I’Allemand D, Wiegand S, Reinehr T, et al. Cardiovascular risk in 26,008 European overweight children as established by a multicenter database. Obesity (Silver Spring). 2008;16(7):1672–9.CrossRefGoogle Scholar
  4. 4.
    Csabi G, Torok K, Jeges S, Molnar D. Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr. 2000;159(1-2):91–4.CrossRefPubMedGoogle Scholar
  5. 5.
    Chu NF, Rimm EB, Wang DJ, Liou HS, Shieh SM. Clustering of cardiovascular disease risk factors among obese schoolchildren: the Taipei Children Heart Study. Am J Clin Nutr. 1998;67(6):1141–6.PubMedGoogle Scholar
  6. 6.
    Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics. 1999;03(6 Pt 1):1175–82.CrossRefGoogle Scholar
  7. 7.
    Bluher M. Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes. 2012;19(5):341–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Prince RL, Kuk JL, Ambler KA, Dhaliwal J, Ball GD. Predictors of metabolically healthy obesity in children. Diabetes Care. 2014;37(5):1462–8.Google Scholar
  9. 9.
    Bluher M. The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr Opin Lipidol. 2010;21(1):38–43.CrossRefPubMedGoogle Scholar
  10. 10.
    Bonora E, Kiechl S, Willeit J, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes. 1998;47(10):1643–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008;168(15):1617–24.CrossRefPubMedGoogle Scholar
  12. 12.
    Bokor S, Frelut ML, Vania A, et al. Prevalence of metabolic syndrome in European obese children. Int J Pediatr Obes. 2008;3 Suppl 2:3–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab. 2004;89(1):108–13.CrossRefPubMedGoogle Scholar
  14. 14.
    Shaibi GQ, Goran MI. Examining metabolic syndrome definitions in overweight Hispanic youth: a focus on insulin resistance. J Pediatr. 2008;152(2):171–6.PubMedCentralCrossRefPubMedGoogle Scholar
  15. 15.
    Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415–28.CrossRefPubMedGoogle Scholar
  16. 16.
    Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Reaven GM. Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease. Am Heart J. 1991;121(4 Pt 2):1283–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Grundy SM. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation. 2002;105(23):2696–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med. 2010;362(6):485–93.PubMedCentralCrossRefPubMedGoogle Scholar
  20. 20.
    Reinehr T, de Sousa G, Toschke AM, Andler W. Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach. Arch Dis Child. 2007;92(12):1067–72.PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Brambilla P, Lissau I, Flodmark CE, et al. Metabolic risk-factor clustering estimation in children: to draw a line across pediatric metabolic syndrome. Int J Obes (Lond). 2007;31(4):591–600.CrossRefGoogle Scholar
  22. 22.
    Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469–80.CrossRefPubMedGoogle Scholar
  23. 23.
    Viner RM, Segal TY, Lichtarowicz-Krynska E, Hindmarsh P. Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child. 2005;90(1):10–4.PubMedCentralCrossRefPubMedGoogle Scholar
  24. 24.
    Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350(23):2362–74.CrossRefPubMedGoogle Scholar
  25. 25.
    Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157(8):821–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Zimmet P, Alberti KG, Kaufman F, et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes. 2007;8(5):299–306.CrossRefPubMedGoogle Scholar
  27. 27.
    Vukovic R, Milenkovic T, Mitrovic K, et al. Preserved insulin sensitivity predicts metabolically healthy obese phenotype in children and adolescents. Eur J Pediatr. 2015;174(12):1649–55Google Scholar
  28. 28.
    Reinehr T, de Sousa G, Andler W. Longitudinal analyses among overweight, insulin resistance, and cardiovascular risk factors in children. Obes Res. 2005;13(10):1824–33.CrossRefPubMedGoogle Scholar
  29. 29.
    Reinehr T, de Sousa G, Toschke AM, Andler W. Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention. Am J Clin Nutr. 2006;84(3):490–6.PubMedGoogle Scholar
  30. 30.
    Sung RY, Yu CW, Chang SK, Mo SW, Woo KS, Lam CW. Effects of dietary intervention and strength training on blood lipid level in obese children. Arch Dis Child. 2002;86(6):407–10.PubMedCentralCrossRefPubMedGoogle Scholar
  31. 31.
    Reinehr T, Kiess W, Kapellen T, Andler W. Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics. 2004;114(6):1569–73.CrossRefPubMedGoogle Scholar
  32. 32.
    Reinehr T, Andler W. Changes in the atherogenic risk factor profile according to degree of weight loss. Arch Dis Child. 2004;89(5):419–22.PubMedCentralCrossRefPubMedGoogle Scholar
  33. 33.
    Coppen AM, Risser JA, Vash PD. Metabolic syndrome resolution in children and adolescents after 10 weeks of weight loss. J Cardiometab Syndr. 2008;3(4):205–10.CrossRefPubMedGoogle Scholar
  34. 34.
    Reinehr T, Kleber M, Toschke AM. Lifestyle intervention in obese children is associated with a decrease of the metabolic syndrome prevalence. Atherosclerosis. 2009;207(1):174–80.CrossRefPubMedGoogle Scholar
  35. 35.
    Savoye M, Shaw M, Dziura J, et al. Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial. JAMA. 2007;297(24):2697–704.CrossRefPubMedGoogle Scholar
  36. 36.
    Kraus WE, Houmard JA, Duscha BD, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. 2002;347(19):1483–92.CrossRefPubMedGoogle Scholar
  37. 37.
    Uusitupa M, Laakso M, Sarlund H, Majander H, Takala J, Penttila I. Long term effects of a very low calorie diet on metabolic control and cardiovascular risk factors in the treatment of obese non-insulin-dependent diabetics. Int J Obes. 1989;13 Suppl 2:163–4.PubMedGoogle Scholar
  38. 38.
    Skov AR, Toubro S, Ronn B, Holm L, Astrup A. Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int J Obes Relat Metab Disord. 1999;23(5):528–36.CrossRefPubMedGoogle Scholar
  39. 39.
    Inoue DS, De Mello MT, Foschini D, et al. Linear and undulating periodized strength plus aerobic training promote similar benefits and lead to improvement of insulin resistance on obese adolescents. J Diabetes Complicat. 2015;29(2):258–64.CrossRefPubMedGoogle Scholar
  40. 40.
    Koerner A, Kratzsch J, Kiess W. Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come. Best Pract Res Clin Endocrinol Metab. 2005;19(4):525–46.CrossRefPubMedGoogle Scholar
  41. 41.
    Rhie YJ, Choi BM, Eun SH, Son CS, Park SH, Lee KH. Association of serum retinol binding protein 4 with adiposity and pubertal development in Korean children and adolescents. J Korean Med Sci. 2011;26(6):797–802.PubMedCentralCrossRefPubMedGoogle Scholar
  42. 42.
    Jurimae J, Gruodyte R, Saar M, et al. Plasma visfatin and adiponectin concentrations in physically active adolescent girls: relationships with insulin sensitivity and body composition variables. J Pediatr Endocrinol Metab. 2011;24(7-8):419–25.CrossRefPubMedGoogle Scholar
  43. 43.
    Reinehr T, Roth CL. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab. 2008;93(11):4479–85.CrossRefPubMedGoogle Scholar
  44. 44.
    Reinehr T, Woelfle J, Wunsch R, Roth CL. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis. J Clin Endocrinol Metab. 2012;97(6):2143–50.CrossRefPubMedGoogle Scholar
  45. 45.
    Agirbasli M, Agaoglu NB, Orak N, et al. Sex hormones and metabolic syndrome in children and adolescents. Metabolism. 2009;58(9):1256–62.CrossRefPubMedGoogle Scholar
  46. 46.
    Reinehr T, Elfers C, Lass N, Roth CL. Irisin and its relation to insulin resistance and puberty in obese children: a longitudinal analysis. J Clin Endocrinol Metab. 2015;100(5):2123–30.CrossRefPubMedGoogle Scholar
  47. 47.
    Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17(1):4–12.PubMedGoogle Scholar
  48. 48.
    Adam TC, Hasson RE, Lane CJ, et al. Fasting indicators of insulin sensitivity: effects of ethnicity and pubertal status. Diabetes Care. 2011;34(4):994–9.PubMedCentralCrossRefPubMedGoogle Scholar
  49. 49.
    Dowling AR, Nedorezov LB, Qiu X, Marino JS, Hill JW. Genetic factors modulate the impact of pubertal androgen excess on insulin sensitivity and fertility. PLoS One. 2013;8(11):e79849.PubMedCentralCrossRefPubMedGoogle Scholar
  50. 50.
    Reinehr T, Toschke AM. Onset of puberty and cardiovascular risk factors in untreated obese children and adolescents: a 1-year follow-up study. Arch Pediatr Adolesc Med. 2009;163(8):709–15.CrossRefPubMedGoogle Scholar
  51. 51.
    Boyne MS, Thame M, Osmond C, et al. The effect of earlier puberty on cardiometabolic risk factors in Afro-Caribbean children. J Pediatr Endocrinol Metab. 2014;27(5-6):453–60.CrossRefPubMedGoogle Scholar
  52. 52.••
    Reinehr T, Wolters B, Knop C, Lass N, Holl RW. Strong effect of pubertal status on metabolic health in obese children: a longitudinal study. J Clin Endocrinol Metab. 2015;100(1):301–8. This large study in > 2000 obese children and adolescents demonstrated an increased cardiovascular risk in pubertal children compared with prepubertal and post pubertal children. The strength are the longitudinal design without intervention proving the hypothesis that entry puberty is associated with higher insulin resistance and its associated cardiovascular risk factors, while moving from mid to late pubertal stage is related to an improvement of cardiovascular risk factors. CrossRefPubMedGoogle Scholar
  53. 53.•
    Tobisch B, Blatniczky L, Barkai L. Cardiometabolic risk factors and insulin resistance in obese children and adolescents: relation to puberty. Pediatr Obes. 2015;10(1):37–44. This cross-sectional study demonstrated an increased cardiovascular risk in pubertal children compared with prepubertal and post pubertal children. CrossRefPubMedGoogle Scholar
  54. 54.
    Pilia S, Casini MR, Foschini ML, et al. The effect of puberty on insulin resistance in obese children. J Endocrinol Investig. 2009;32(5):401–5.CrossRefGoogle Scholar
  55. 55.
    Pinhas-Hamiel O, Lerner-Geva L, Copperman NM, Jacobson MS. Lipid and insulin levels in obese children: changes with age and puberty. Obesity (Silver Spring). 2007;15(11):2825–31.CrossRefGoogle Scholar
  56. 56.
    Bluher S, Molz E, Wiegand S, et al. Body mass index, waist circumference, and waist-to-height ratio as predictors of cardiometabolic risk in childhood obesity depending on pubertal development. J Clin Endocrinol Metab. 2013;98(8):3384–93.CrossRefPubMedGoogle Scholar
  57. 57.
    de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110(16):2494–7.CrossRefPubMedGoogle Scholar
  58. 58.
    Reinehr T, Wabitsch M, Kleber M, de Sousa G, Denzer C, Toschke AM. Parental diabetes, pubertal stage, and extreme obesity are the main risk factors for prediabetes in children and adolescents: a simple risk score to identify children at risk for prediabetes. Pediatr Diabetes. 2009;10(6):395–400.CrossRefPubMedGoogle Scholar
  59. 59.
    Kleber M, Lass N, Papcke S, Wabitsch M, Reinehr T. One-year follow-up of untreated obese white children and adolescents with impaired glucose tolerance: high conversion rate to normal glucose tolerance. Diabet Med. 2010;27(5):516–21.CrossRefPubMedGoogle Scholar
  60. 60.•
    Goran MI, Gower BA. Longitudinal study on pubertal insulin resistance. Diabetes. 2001;50(11):2444–50. This longitudinal study analyses of the impact of puberty on insulin sensitivity and its relation to progression to type 2 diabetes mellitus. It used sophisticated measurements such as dual energy x-ray absorptiometry for determination of body fat and insulin modified intravenous glucose tolerance test to describe b-cell function. This study indicates that the failure to increase insulin response to glucose in response to the fall in insulin sensitivity may be one factor in the pathogenesis of progression to pediatric type 2 diabetes in at risk population such as overweight adolescents. CrossRefPubMedGoogle Scholar
  61. 61.
    Yin J, Li M, Xu L, et al. Insulin resistance determined by Homeostasis Model Assessment (HOMA) and associations with metabolic syndrome among Chinese children and teenagers. Diabetol Metab Syndr. 2013;5(1):71.PubMedCentralCrossRefPubMedGoogle Scholar
  62. 62.
    Hannon TS, Janosky J, Arslanian SA. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res. 2006;60(6):759–63.CrossRefPubMedGoogle Scholar
  63. 63.
    Goran MI, Shaibi GQ, Weigensberg MJ, Davis JN, Cruz ML. Deterioration of insulin sensitivity and beta-cell function in overweight Hispanic children during pubertal transition: a longitudinal assessment. Int J Pediatr Obes. 2006;1(3):139–45.PubMedCentralCrossRefPubMedGoogle Scholar
  64. 64.
    Xu L, Li M, Yin J, et al. Change of Body Composition and Adipokines and Their Relationship with Insulin Resistance across Pubertal Development in Obese and Nonobese Chinese Children: the BCAMS Study. Int J Endocrinol. 2012;2012:389108.PubMedCentralCrossRefPubMedGoogle Scholar
  65. 65.••
    Kelly LA, Lane CJ, Weigensberg MJ, Toledo-Corral CM, Goran MI. Pubertal changes of insulin sensitivity, acute insulin response, and beta-cell function in overweight Latino youth. J Pediatr. 2011;158(3):442–6. This longitudinal study is a hallmark in the analyses of the impact of puberty on insulin sensitivity in a large cohort of 253 obese Latino children. It used sophisticated measurements such as dual energy x-ray absorptiometry for determination of body fat and insulin modified intravenous glucose tolerance test to describe b-cell function. This study indicates that insulin secretion fails after Tanner stage 3 due to beta-cell deterioration. PubMedCentralCrossRefPubMedGoogle Scholar
  66. 66.
    Brufani C, Tozzi A, Fintini D, et al. Sexual dimorphism of body composition and insulin sensitivity across pubertal development in obese Caucasian subjects. Eur J Endocrinol. 2009;160(5):769–75.CrossRefPubMedGoogle Scholar
  67. 67.
    Raab J, Haupt F, Kordonouri O, et al. Continuous rise of insulin resistance before and after the onset of puberty in children at increased risk for type 1 diabetes - a cross-sectional analysis. Diabetes Metab Res Rev. 2013;29(8):631–5.CrossRefPubMedGoogle Scholar
  68. 68.•
    Jeffery AN, Metcalf BS, Hosking J, Streeter AJ, Voss LD, Wilkin TJ. Age before stage: insulin resistance rises before the onset of puberty: a 9-year longitudinal study (EarlyBird 26). Diabetes Care. 2012;35(3):536–41. This longitudinal prospective cohort study of healthy children was the first to describe an increase of insulin resistance in mid-childhood some years before puberty. This study was based on sophisticated measurements such as dual energy x-ray absorptiometry for determination of body fat. However, measurement of insulin resistance was based only on the HOMA model. PubMedCentralCrossRefPubMedGoogle Scholar
  69. 69.
    Hainan E. Diabetes and puberty. Am J Nurs. 2014;114(10):12.CrossRefPubMedGoogle Scholar
  70. 70.
    Chu L, Riddell MC, Schneiderman JE, McCrindle BW, Hamilton JK. The effect of puberty on fat oxidation rates during exercise in overweight and normal-weight girls. J Appl Physiol (1985. 2014;116(1):76–82.CrossRefGoogle Scholar
  71. 71.
    Spruijt-Metz D, Belcher BR, Hsu YW, et al. Temporal relationship between insulin sensitivity and the pubertal decline in physical activity in peripubertal Hispanic and African American females. Diabetes Care. 2013;36(11):3739–45.PubMedCentralCrossRefPubMedGoogle Scholar
  72. 72.••
    Kayser BD, Toledo-Corral CM, Alderete TL, Weigensberg MJ, Goran MI. Temporal relationships between adipocytokines and diabetes risk in Hispanic adolescents with obesity. Obesity (Silver Spring). 2015;23(7):1479–85. This longitudinal study helps to understand how puberty can influence insulin resistance. This study is based on sophisticated measurements such as dual energy x-ray absorptiometry for determination of body fat and insulin modified intravenous glucose tolerance test to describe b-cell function. This study demonstrates that several adipocytokines changed during puberty. However, the relationships to insulin resistance were only weak. CrossRefGoogle Scholar
  73. 73.
    Korner A, Neef M, Friebe D, et al. Vaspin is related to gender, puberty and deteriorating insulin sensitivity in children. Int J Obes (Lond). 2011;35(4):578–86.CrossRefGoogle Scholar
  74. 74.
    Santoro N, Perrone L, Cirillo G, et al. Variations of retinol binding protein 4 levels are not associated with changes in insulin resistance during puberty. J Endocrinol Investig. 2009;32(5):411–4.CrossRefGoogle Scholar
  75. 75.
    Reinehr T, Roth CL. A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight loss. Int J Obes (Lond). 2010;34(5):852–8.CrossRefGoogle Scholar
  76. 76.
    Sorensen K, Aksglaede L, Munch-Andersen T, et al. Sex hormone-binding globulin levels predict insulin sensitivity, disposition index, and cardiovascular risk during puberty. Diabetes Care. 2009;32(5):909–14.PubMedCentralCrossRefPubMedGoogle Scholar
  77. 77.
    Qiu X, Dao H, Wang M, et al. Insulin and leptin signaling interact in the mouse kiss1 neuron during the peripubertal period. PLoS One. 2015;10(5):e0121974.PubMedCentralCrossRefPubMedGoogle Scholar
  78. 78.
    Astiz S, Gonzalez-Bulnes A, Astiz I, Barbero A, Perez-Solana ML, Garcia-Real I. Advanced onset of puberty after metformin therapy in swine with thrifty genotype. Exp Physiol. 2014;99(9):1241–52.CrossRefPubMedGoogle Scholar
  79. 79.
    Rynders C, Weltman A, Delgiorno C, et al. Lifestyle intervention improves fitness independent of metformin in obese adolescents. Med Sci Sports Exerc. 2012;44(5):786–92.PubMedCentralCrossRefPubMedGoogle Scholar
  80. 80.
    Wiegand S, L’Allemand D, Hubel H, et al. Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective, placebo-controlled, randomized study. Eur J Endocrinol. 2010;163(4):585–92.CrossRefPubMedGoogle Scholar
  81. 81.
    Rasmussen SS, Glumer C, Sandbaek A, Lauritzen T, Borch-Johnsen K. Progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screening programme in general practice: the ADDITION Study, Denmark. Diabetologia. 2007;50(2):293–7.CrossRefPubMedGoogle Scholar
  82. 82.
    Rasmussen SS, Glumer C, Sandbaek A, Lauritzen T, Borch-Johnsen K. Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3-year follow-up in the ADDITION study, Denmark. Diabetologia. 2008;51(2):249–57.CrossRefPubMedGoogle Scholar
  83. 83.
    Kleber M, Desousa G, Papcke S, Wabitsch M, Reinehr T. Impaired glucose tolerance in obese white children and adolescents: three to five-year follow-up in untreated patients. Exp Clin Endocrinol Diabetes. 2011;119(3):172–6.Google Scholar
  84. 84.
    Kleber M, Lass N, Papcke S, Wabitsch M, Reinehr T. One year follow-up of untreated obese white children and adolescents with impaired glucose tolerance: high conversion rate to normal glucose tolerance. Diabet Med. 2010;27(5):516–21.Google Scholar
  85. 85.
    Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med. 2006;25(1):127–41.CrossRefPubMedGoogle Scholar
  86. 86.
    Mente A, Yusuf S, Islam S, et al. Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries. J Am Coll Cardiol. 2010;55(21):2390–8.CrossRefPubMedGoogle Scholar
  87. 87.
    Baldassarre D, Werba JP, Castelnuovo S, et al. The metabolic syndrome predicts carotid intima-media thickness no better than the sum of individual risk factors in a lipid clinic population. Atherosclerosis. 2010;210(1):214–9.CrossRefPubMedGoogle Scholar
  88. 88.
    Fadini GP, Coracina A, Inchiostro S, Tiengo A, Avogaro A, de Kreutzenberg SV. A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. Eur J Cardiovasc Prev Rehabil. 2008;15(2):190–6.CrossRefPubMedGoogle Scholar
  89. 89.
    Reinehr T, Wunsch R, Putter C, Scherag A. Relationship between carotid intima-media thickness and metabolic syndrome in adolescents. J Pediatr. 2013;163(2):327–32.Google Scholar
  90. 90.
    Reinehr T, Wunsch R, de Sousa G, Toschke AM. Relationship between metabolic syndrome definitions for children and adolescents and intima-media thickness. Atherosclerosis. 2008;199(1):193–200.CrossRefPubMedGoogle Scholar
  91. 91.
    Magnussen CG, Koskinen J, Chen W, et al. Pediatric metabolic syndrome predicts adulthood metabolic syndrome, subclinical atherosclerosis, and type 2 diabetes mellitus but is no better than body mass index alone: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study. Circulation. 2010;122(16):1604–11.PubMedCentralCrossRefPubMedGoogle Scholar
  92. 92.
    Allard P, Delvin EE, Paradis G, et al. Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents. Clin Chem. 2003;49(4):644–9.CrossRefPubMedGoogle Scholar
  93. 93.
    Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med. 2002;19(7):527–34.CrossRefPubMedGoogle Scholar
  94. 94.
    Chan CL, Pyle L, Newnes L, Nadeau KJ, Zeitler PS, Kelsey MM. Continuous glucose monitoring and its relationship to hemoglobin A1c and oral glucose tolerance testing in obese and prediabetic youth. J Clin Endocrinol Metab. 2015;100(3):902–10.CrossRefPubMedGoogle Scholar
  95. 95.
    Libman IM, Barinas-Mitchell E, Bartucci A, Robertson R, Arslanian S. Reproducibility of the oral glucose tolerance test in overweight children. J Clin Endocrinol Metab. 2008;93(11):4231–7.PubMedCentralCrossRefPubMedGoogle Scholar
  96. 96.
    Olza J, Aguilera CM, Gil-Campos M, et al. Waist-to-height ratio, inflammation and CVD risk in obese children. Public Health Nutr. 2014;17(10):2378–85.Google Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of Pediatric Endocrinology, Diabetes, and Nutrition Medicine, Vestische Children’s HospitalUniversity of Witten/HerdeckeDattelnGermany

Personalised recommendations